Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-14 4:55 pm Purchase | 2024-09-30 | 13G | Outlook Therapeutics, Inc. OTLK | GREAT POINT PARTNERS LLC | 2,481,973 9.990% | 250,649 (+11.23%) | Filing History |
2024-11-07 4:17 pm Sale | 2024-09-30 | 13G | Outlook Therapeutics, Inc. OTLK | Velan Capital Investment Management LP | 750,000 3.100% | -500,000 (-40.00%) | Filing History |
2024-04-17 9:38 pm Purchase | 2024-04-15 | 13D | Outlook Therapeutics, Inc. OTLK | Syntone Ventures LLC | 2,776,867 11.400% | 2,776,867 (New Position) | Filing History |
2024-04-08 4:10 pm Purchase | 2024-04-01 | 13G | Outlook Therapeutics, Inc. OTLK | GREAT POINT PARTNERS LLC | 2,231,324 9.990% | 2,231,324 (New Position) | Filing History |
2024-03-28 4:16 pm Purchase | 2024-03-18 | 13G | Outlook Therapeutics, Inc. OTLK | Velan Capital Investment Management LP | 1,250,000 5.600% | 1,250,000 (New Position) | Filing History |
2024-03-28 4:00 pm Purchase | 2024-03-18 | 13G | Outlook Therapeutics, Inc. OTLK | TANG CAPITAL PARTNERS LP | 2,215,851 9.990% | 2,215,851 (New Position) | Filing History |
2024-03-20 5:24 pm Purchase | 2024-03-18 | 13D | Outlook Therapeutics, Inc. OTLK | GMS Ventures & Investments | 9,266,645 37.000% | 9,266,645 (New Position) | Filing History |
2024-01-31 4:01 pm Sale | 2024-01-25 | 13D | Outlook Therapeutics, Inc. OTLK | Tenshi Healthcare Pte. Ltd. | 831,851 6.400% | -135,723 (-14.03%) | Filing History |
2023-11-29 4:01 pm Sale | 2023-11-10 | 13D | Outlook Therapeutics, Inc. OTLK | Tenshi Healthcare Pte. Ltd. | 967,575 7.400% | -181,552 (-15.80%) | Filing History |
2023-02-17 8:14 pm Purchase | 2022-12-31 | 13G | Outlook Therapeutics, Inc. OTLK | Hope Jason | 1,000,000 7.800% | 249,382 (+33.22%) | Filing History |
2022-12-29 4:43 pm Purchase | 2022-12-28 | 13D | Outlook Therapeutics, Inc. OTLK | GMS Ventures & Investments | 3,563,876 27.900% | 711,521 (+24.95%) | Filing History |
2022-07-07 9:51 pm Sale | 2022-07-05 | 13D | Outlook Therapeutics, Inc. OTLK | Tenshi Healthcare Pte. Ltd. | 1,149,126 10.200% | -1,703,229 (-59.71%) | Filing History |
2022-07-07 5:20 pm Purchase | 2022-07-05 | 13D | Outlook Therapeutics, Inc. OTLK | GMS Ventures & Investments | 2,852,355 25.100% | 2,852,355 (New Position) | Filing History |
2022-04-22 4:30 pm Sale | 2022-04-21 | 13D | Outlook Therapeutics, Inc. OTLK | Tenshi Healthcare Pte. Ltd. | 2,852,355 25.600% | -1,149,126 (-28.72%) | Filing History |
2022-04-01 4:31 pm Purchase | 2022-03-18 | 13G | Outlook Therapeutics, Inc. OTLK | Hope Jason | 750,618 6.690% | 750,618 (New Position) | Filing History |
2022-02-01 4:58 pm Unchanged | 2022-02-01 | 13D | Outlook Therapeutics, Inc. OTLK | Tenshi Healthcare Pte. Ltd. | 4,001,482 35.700% | 0 (Unchanged) | Filing History |
2021-12-01 5:27 pm Purchase | 2021-11-29 | 13D | Outlook Therapeutics, Inc. OTLK | Tenshi Healthcare Pte. Ltd. | 4,001,482 35.500% | 850,681 (+27.00%) | Filing History |
2021-02-04 8:55 pm Purchase | 2021-02-03 | 13D | Outlook Therapeutics, Inc. OTLK | Syntone Ventures LLC | 991,152 11.700% | 191,152 (+23.89%) | Filing History |
2021-02-02 5:27 pm Purchase | 2021-02-02 | 13D | Outlook Therapeutics, Inc. OTLK | Tenshi Healthcare Pte. Ltd. | 3,150,800 38.600% | 418,000 (+15.30%) | Filing History |
2021-01-05 08:55 am Sale | 2020-12-31 | 13G | Outlook Therapeutics, Inc. OTLK | SABBY MANAGEMENT, LLC | 81,253 11.000% | -66,385 (-44.96%) | Filing History |